| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,384 |
4,801 |
$360K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,584 |
3,703 |
$185K |
| 80053 |
Comprehensive metabolic panel |
4,412 |
3,463 |
$95K |
| 70450 |
Computed tomography, head or brain; without contrast material |
919 |
694 |
$61K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
592 |
566 |
$44K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
494 |
376 |
$23K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
105 |
96 |
$20K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
138 |
130 |
$15K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
281 |
237 |
$15K |
| 87400 |
|
739 |
677 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
331 |
300 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
2,047 |
1,638 |
$7K |
| 81003 |
|
810 |
709 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12 |
12 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
755 |
670 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
219 |
162 |
$5K |
| 81001 |
|
1,451 |
1,202 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
362 |
347 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,493 |
2,038 |
$3K |
| 85027 |
|
5,122 |
3,914 |
$3K |
| 84484 |
|
1,827 |
1,053 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,325 |
1,569 |
$3K |
| 85610 |
|
1,446 |
1,113 |
$2K |
| 83690 |
|
1,212 |
1,022 |
$1K |
| 81025 |
|
510 |
474 |
$1K |
| A9270 |
Non-covered item or service |
1,274 |
395 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
78 |
57 |
$1K |
| 85730 |
|
910 |
681 |
$1K |
| 83735 |
|
676 |
499 |
$885.56 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
264 |
211 |
$856.56 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,018 |
797 |
$792.14 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
919 |
698 |
$725.72 |
| 87040 |
|
200 |
126 |
$491.34 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
91 |
68 |
$465.35 |
| 87420 |
|
12 |
12 |
$449.70 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
23 |
15 |
$442.05 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,801 |
1,387 |
$406.23 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
36 |
35 |
$322.17 |
| 80061 |
Lipid panel |
104 |
78 |
$274.27 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
176 |
119 |
$261.43 |
| 87077 |
|
55 |
40 |
$134.22 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
30 |
24 |
$50.36 |
| 82150 |
|
49 |
43 |
$48.52 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
77 |
59 |
$23.03 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
37 |
$21.35 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
21 |
17 |
$19.76 |
| 36415 |
Collection of venous blood by venipuncture |
73 |
55 |
$1.27 |
| J7050 |
Infusion, normal saline solution, 250 cc |
18 |
13 |
$0.00 |
| 83605 |
|
226 |
175 |
$0.00 |
| 83880 |
|
224 |
159 |
$0.00 |
| 84703 |
|
12 |
12 |
$0.00 |
| 96376 |
|
34 |
24 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
24 |
15 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
12 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
16 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
73 |
53 |
$0.00 |
| 87186 |
|
55 |
40 |
$0.00 |